Reneuron Group PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reneuron Group PLC with three other
companies in this sector in UNITED KINGDOM :
Bioventix Plc
(2020
sales of £10.31 million [US$14.01 million]
),
IXICO PLC
(£9.53 million [US$12.95 million]
of which 100%
was Pharmaceutical), and
Fusion Antibodies PLC
(£3.90 million [US$5.29 million]
).
Sales Analysis.
Sales increased substantially in 2020:
Reneuron Group PLC reported sales of £6.07 million (US$8.24 million)
for the
fiscal
year ending
March of 2020.
This
represents
an
increase of 12,277.6%
versus 2019, when the company's sales were £49,000.00 .